News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs
Bonum Therapeutics, a Seattle-based biomanufacturer, is moving into new offices in South Lake Union and plans to double its workforce in pursuit of producing its

Genome recording makes living cells their own historians
The University of Washington School of Medicine has developed the capability for genomes to store information in real-time about a variety of biological events inside

Catching up with WSU’s Steve Gleason Institute
The Steve Gleason Institute has become a leading treatment center for neurodegenerative diseases in the Pacific Northwest. Named after former Washington State University and New

DOD enlists Evotec subsidiary in antibody manufacturing program, awards up to $39M
The Department of Defense (DOD) has partnered with Just – Evotec Biologics, a Seattle-based subsidiary of Evotec, to enhance large-scale manufacturing capabilities under the DOD’s

$5.25M from the Kuni Foundation propels innovative adult oncology research
Principal investors at Fred Hutch Cancer Center and UW Medicine received $5.25 million in grants from the Kuni Foundation, a Vancouver, Washington-based organization dedicated to

Seattle biotech company RareCyte raises $20M to accelerate product development
RareCyte, a Seattle-based biotech company, recently announced that it has raised $20 million from new and current investors. This funding boost is set to significantly

Cancer screening tech startup Ezra opens two locations in Seattle area
Ezra, a health technology startup focused on cancer screening, opened two new locations in the Seattle area this week. Emphasizing early detection, Ezra specializes in

What’s the Best City for New College Graduates?
Seattle has been ranked as the third-best city for new college graduates according to a recent study by Zumper. The study analyzed the country’s 100

Omeros names chief accounting officer from within
Omeros Corp., a biopharmaceutical company based in Seattle, recently named David Borges their new chief accounting officer. Borges, who joined Omeros in June 2020, has

Clay Siegall-led biotech inks lease for Bothell headquarters
Immunome Inc., a biotechnology company specializing in targeted cancer therapies, recently signed a lease to move into the headquarters at Bothell’s Alloy Innovation Center. Totaled

Cancer-fighting biotech startup InduPro raises $85M round
InduPro Inc., a biotechnology company dual- headquartered in Seattle and Cambridge, Massachusetts, recently announced its success in raising $85 million in Series A round funding.

Lundbeck to Present a Breadth of Migraine and Cluster Headache Data at the 66th Annual Scientific Meeting of the American Headache Society
Lundbeck, a biopharmaceutical company based in Bothell, Washington, recently shared its positive findings on VYEPTI, their new prescription medicine for treating migraines in adults. New
